Brief: Theravet Lauches Biocera-Vet Product Line In United States
June 30 (Reuters) - Theravet SA ALVET.PA :
* THERAVET ANNONCES THE COMMERCIAL LAUNCH OF ITS BIOCERA-VET
PRODUCT LINE IN THE UNITED STATES OF AMERICA
* INITIAL FOCUS ON STATES OF TEXAS, FLORIDA AND CAROLINAS
* COMMERCIAL LAUNCH OF BIOCERA-VET(®) BONE SURGERY
READY-TO-USE,
BIOCERA-VET(®) GRANULES AND BIOCERA-VET(®) OSTEOSARCOMA
READY-TO-USE IN UNITED STATES
Source text for Eikon: ID:nBwblLjJTa
Further company coverage: ALVET.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Theravet SA
See all newsBrief: Theravet Announces Setting Up Of An Equity-Linked Financing Facility
Brief: TheraVet Provides Update On 2023 Half-Year Development And Portfolio Strategy
Brief: Theravet Announces 300% Increase In Participating Centers In Its Osteosarcoma Program
Brief: Theravet End-Dec Cash Position Of EUR 3.19 Mln
Brief: Theravet Signs New Distribution Agreement For Its Biocera-Vet With Elvetis